Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
Recombinant factor VIII for the prevention of bleeding in patients with severe haemophilia A
undergoing major surgery while receiving emicizumab prophylaxis